Table 1.
Patients’ characteristics
| Parameter | Total N = 40 |
|---|---|
| Gleason score | |
| 6 | 8 (20.0%) |
| 7 | 12 (30.0%) |
| 8–10 | 20 (50.0%) |
| T stage (AJCC 8th) | |
| T2 | 33 (82.5%) |
| T3 | 5 (12.5%) |
| T4 | 1 (2.5%) |
| aTx | 1 (2.5%) |
| Risk group | |
| Low | 2 (5.0%) |
| Intermediate | 14 (35.0%) |
| High | 23 (57.5%) |
| aUnknown | 1 (2.5%) |
| Initial PSA | |
| < 10 ng/mL | 16 (40.0%) |
| 10–19.9 ng/mL | 13 (32.5%) |
| ≥ 20 ng/mL | 11 (27.5%) |
| Parameter | Volume (cc) |
| CTV/median (range, cc) | 92.85 (48.08–164.94) |
| ≤ 100.00 | 68.44 (48.08–94.5) (52.5%) |
| > 100.00 | 121.37 (107.42–164.94) (47.5%) |
| Rectum/median (range, cc) | 50.66 (34.59–75.29) |
| ≤ 50.00 | 44.04 (34.59–49.89) (47.5%) |
| > 50.00 | 56.19 (50.41–75.29) (52.5%) |
aOne patient received transurethral prostatic resection (TURP) before CIRT, therefore, his T stage and risk profile are unknown